Gabapentin Enacarbil Market

Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
Gabapentin Enacarbil Market aims to provide a comprehensive presentation of the global market for Gabapentin Enacarbil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin Enacarbil. Gabapentin Enacarbil Market contains market size and forecasts of Gabapentin Enacarbil in global, including the following market information:
Global Gabapentin Enacarbil Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Gabapentin Enacarbil Market Sales, 2018-2023, 2024-2035, (K Units)
Global top five Gabapentin Enacarbil companies in 2022 (%)
The global Gabapentin Enacarbil market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Capsule Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Gabapentin Enacarbil include Arbor Pharma, Astellas, GlaxoSmithKline, Glenmark Pharma, Pfizer, Depomed, Teva, Mylan and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gabapentin Enacarbil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gabapentin Enacarbil Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Gabapentin Enacarbil Market Segment Percentages, by Type, 2022 (%)
Capsule
Tablet
Global Gabapentin Enacarbil Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Gabapentin Enacarbil Market Segment Percentages, by Application, 2022 (%)
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
Global Gabapentin Enacarbil Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Gabapentin Enacarbil Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gabapentin Enacarbil revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gabapentin Enacarbil revenues share in global market, 2022 (%)
Key companies Gabapentin Enacarbil sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gabapentin Enacarbil sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arbor Pharma
Astellas
GlaxoSmithKline
Glenmark Pharma
Pfizer
Depomed
Teva
Mylan
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gabapentin Enacarbil, market overview.
Chapter 2: Global Gabapentin Enacarbil market size in revenue and volume.
Chapter 3: Detailed analysis of Gabapentin Enacarbil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gabapentin Enacarbil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gabapentin Enacarbil capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.